This topic contains a solution. Click here to go to the answer

Author Question: PLCP stands for ________. A) Private Layer Convergence Protocol B) Physical Layer Convergence ... (Read 114 times)

chads108

  • Hero Member
  • *****
  • Posts: 507
PLCP stands for ________.
 
  A) Private Layer Convergence Protocol
  B) Physical Layer Convergence Procedure
  C) Packet Linking Correction Protocol
  D) Physical Login Correction Principles

Question 2

The core function of the ________ layer is to serve as a conduit for transfer of data from a given sender to a given receiver.
 
  A) physical
  B) virtual
  C) metaphysical
  D) accessory



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

josephsuarez

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

B

Answer to Question 2

A




chads108

  • Member
  • Posts: 507
Reply 2 on: Jul 7, 2018
YES! Correct, THANKS for helping me on my review


atrochim

  • Member
  • Posts: 331
Reply 3 on: Yesterday
Gracias!

 

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

There are 20 feet of blood vessels in each square inch of human skin.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library